Investor’s Business Daily: Pharmacy Benefit Managers: We’d Be Stuck In The Middle Without Them
August 07, 2018
PBMs don’t just negotiate discounts for their customers; they encourage competition in the costly drug market....
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
Bloomberg: Facing Wave of Opioid Lawsuits, Drug Companies Sprinkle Charity on Hard-Hit Areas
August 02, 2018
The contributions mostly began after the wave of lawsuits. They are small in comparison with the amount companies could be...
Health Affairs: Spending On Prescription Drugs In The US: Where Does All The Money Go?
August 02, 2018
Total US expenditures on pharmaceutical drugs…were $480 billion…Two-thirds of this total was captured by drug manufacturers in the form of...
Kaiser Health News: Drug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
July 30, 2018
Against the backdrop of high drug prices and its heaviest political expenditures in years, the pharmaceutical industry is directing substantial...
The News Virginian: Advocates fight for affordable drugs
July 27, 2018
Though drug makers continue to raise prices out of proportion to increases in value, PBMs are doing their job by...
The Hill: High hopes for President Trump’s drug pricing plan
July 26, 2018
Analysts have found no correlation between rebates for brand-name drugs and cost increases....
Kaiser Health News: Déjà Voodoo: Pharma’s Promises To Curb Drug Prices Have Been Heard Before
July 25, 2018
History’s lesson, they say, is that price-restraint vows last only as long as it is politically necessary for companies to...
USA Today: Are you getting the best price for your prescriptions? Some strategies to pay less
July 25, 2018
Make sure you understand your pharmacy benefit and your insurance plan, said Mark Merritt...
The New York Times: Merck to Lower Prices on Some Drugs, but Not Its Blockbusters
July 20, 2018
It did not cut the prices of any blockbusters like the cancer treatment Keytruda or the diabetes drug Januvia....
BioCentury: BioPharma, PBMs Battle Over HHS Drug Pricing Blueprint
July 17, 2018
“Drugmakers — not any other industry — are responsible for the prices they set.”...
Politico: PhRMA, generic drug lobby join HHS’ call for overhauling rebates
July 17, 2018
“There’s absolutely no evidence to support the notion that drug companies will lower their prices if they no longer offer...
Bloomberg: Many Drugmakers Ignore Trump—and Raise Prices Anyway
July 13, 2018
In the first 10 days of July, at least ten other drugmakers raised prices on at least 20 brand-name medicines...